SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare/cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
तुलना करने के लिए मीट्रिक्स | SBTX | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधSBTXपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | −17.2x | −3.0x | −0.5x | |
PEG अनुपात | −0.68 | −0.04 | 0.00 | |
क़ीमत/बुक | 9.9x | 1.0x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 16.5x | 6.5x | 2.9x | |
अपसाइड (विश्लेषक लक्ष्य) | 190.9% | 236.4% | 45.8% | |
उचित मूल्य अपसाइड | अनलॉक करें | 13.3% | 8.6% | अनलॉक करें |